Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
6.35
+0.14 (2.25%)
Jul 9, 2026, 2:02 PM EDT - Market open
Achieve Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 28.08 | 20.93 | 12.75 | 15.55 | 24.77 | 43.02 |
Short-Term Investments | 1.19 | 15.48 | 21.61 | - | - | - |
Cash & Short-Term Investments | 29.27 | 36.4 | 34.36 | 15.55 | 24.77 | 43.02 |
Cash Growth | 25.91% | 5.95% | 121.02% | -37.24% | -42.42% | 20.00% |
Other Receivables | - | - | - | 0.11 | 0.11 | 0.15 |
Total Trade Receivables | - | - | - | 0.11 | 0.11 | 0.15 |
Other Current Assets | 1.79 | 3.49 | 2.11 | 1.33 | 2.45 | 1.42 |
Total Current Assets | 31.06 | 39.89 | 36.47 | 16.98 | 27.33 | 44.59 |
Net Property, Plant & Equipment | 0.05 | 0.06 | 0.12 | 0.07 | 0.12 | 0.06 |
Other Intangible Assets | 0.7 | 0.75 | 0.97 | 1.2 | 1.42 | 1.64 |
Goodwill | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 |
Other Long-Term Assets | 0.27 | 0.05 | 0.04 | 0.09 | 0.07 | 0.18 |
Total Assets | 33.11 | 41.79 | 38.63 | 19.37 | 29.97 | 47.52 |
Accounts Payable | 0.83 | 0.87 | 1.95 | 0.62 | 1.66 | 0.84 |
Accrued Expenses | 5.37 | 2.89 | 4.68 | 2.94 | 3.81 | 3.64 |
Current Portion of Long-Term Debt | 5.63 | 3.77 | 0.06 | 16.73 | 16.13 | 0.07 |
Other Current Liabilities | - | 1.56 | - | 0.53 | - | - |
Total Current Liabilities | 11.83 | 9.08 | 6.68 | 20.81 | 21.6 | 4.55 |
Long-Term Debt | 9.32 | 11.19 | 9.84 | 0.01 | 0.07 | 14.92 |
Other Long-Term Liabilities | 1.27 | - | 1.15 | - | - | - |
Total Long-Term Liabilities | 10.59 | 11.19 | 10.99 | 0.01 | 0.07 | 14.92 |
Total Liabilities | 22.43 | 20.27 | 17.73 | 20.82 | 21.67 | 19.47 |
Common Stock | 0.12 | 0.12 | 0.1 | 0.09 | 0.09 | 0.08 |
Additional Paid-in Capital | 280.95 | 281.61 | 226.34 | 164.21 | 144.15 | 121.55 |
Accumulated Other Comprehensive Income | 0 | 0.01 | 0.03 | 0 | 0 | 0 |
Retained Earnings | -270.39 | -260.23 | -205.58 | -165.75 | -135.94 | -93.59 |
Shareholders' Equity | 10.68 | 21.52 | 20.9 | -1.45 | 8.3 | 28.04 |
Total Liabilities & Equity | 33.11 | 41.79 | 38.63 | 19.37 | 29.97 | 47.52 |
Total Debt | 14.95 | 14.95 | 9.89 | 16.73 | 16.2 | 14.99 |
Net Cash (Debt) | 14.32 | 21.45 | 24.47 | -1.19 | 8.57 | 28.03 |
Net Cash Growth | -33.27% | -12.32% | - | - | -69.41% | -21.45% |
Net Cash Per Share | 0.30 | 0.49 | 0.76 | -0.06 | 0.81 | 3.45 |
Book Value | 10.68 | 21.52 | 20.9 | -1.45 | 8.3 | 28.04 |
Book Value Per Share | 0.22 | 0.49 | 0.65 | -0.07 | 0.78 | 3.45 |
Tangible Book Value | 8.95 | 19.73 | 18.89 | -3.68 | 5.85 | 25.37 |
Tangible Book Value Per Share | 0.19 | 0.45 | 0.59 | -0.19 | 0.55 | 3.12 |